CPC Diagnostics
CPC Diagnostics is a privately held Indian medical laboratory diagnostic equipment supplier, founded 1987 in Chennai, distributing multi-modality analyzers (biochemistry, immunoassay, molecular, hematology, point-of-care, electrolyte) to clinical laboratories and healthcare facilities across India.
- Company typePrivate
- Founded1987
- HeadquartersChennai, India
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What CPC Diagnostics does
CPC Diagnostics is a privately held Indian medical laboratory diagnostic equipment supplier, founded in 1987 and headquartered in Chennai. The company distributes a broad portfolio of diagnostic analyzers across eight categories: biochemistry, immunoassay (IFA, CLIA, Trace, Immunoblot), molecular diagnostics, hematology, point-of-care (iChrom), electrolyte analysis, and pre-analytical automation. Specific platforms include the iFlash 1200/1800/3000 CLIA series, Fluoromat 50 (IFA), Kryptor Compact Plus (Trace), Plexmat 4 (Immunoblot), LabScan 3D and LabScan 100 (molecular diagnostics), Dynacount 3D Plus and SedRate Pro (hematology), and iChrom 2/3 (point-of-care). Differentiators cited across products are accuracy, precision, and ease of use; no proprietary patents, certifications, or AI features are disclosed.
CPC Diagnostics firmographics
Firmographics- Name
- CPC Diagnostics
- Legal name
- CPC Diagnostics
- Website
- https://cpcdiagnostics.in
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- CPC Diagnostics is a privately held Indian medical laboratory diagnostic equipment supplier, founded 1987 in Chennai, distributing multi-modality analyzers (biochemistry, immunoassay, molecular, hematology, point-of-care, electrolyte) to clinical laboratories and healthcare facilities across India.
- Ownership category
- akta.pro rank
Where CPC Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Chennai
- HQ country
- India
- HQ region
- Asia
Markets served
CPC Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Distribution channels1 record
Marketing channels2 records
CPC Diagnostics product offering
Product offeringCore offering
CPC Diagnostics is a dedicated provider of medical laboratory diagnostic equipment to the clinical laboratory industry, supplying analyzers across biochemistry, immunoassay (IFA, CLIA, Trace, Immunoblot), molecular diagnostics, hematology (3-part cell counters and ESR), point-of-care, electrolyte analysis, and pre-analytical automation categories. The company distributes and supports these diagnostic instruments primarily to clinical and medical diagnostic laboratories and to hospitals and clinics in India, offering a multi-modality portfolio under one supplier.
Product overview
CPC Diagnostics is a medical laboratory equipment supplier based in India offering a comprehensive portfolio of diagnostic instruments. The product portfolio includes multiple core product categories: Biochemistry Analyzers for biochemical testing; Immunoassay Analyzers encompassing IFA (Fluoromat 50), CLIA (iFlash 1200, iFlash 1800, iFlash 3000), Trace (Kryptor Compact Plus), and Immunoblot (Plexmat 4) technologies; Molecular Diagnostics platforms (LabScan 3D, LabScan 100); Hematology Analyzers including 3-part cell counters (Dynacount 3D Plus) and ESR analyzers (SedRate Pro); Point-of-Care testing devices (iChrom 2, iChrom 3); Electrolyte Analyzers; and Pre-analytical Automation systems. This modular architecture allows laboratories to select specific analyzers based on their testing requirements across clinical chemistry, immunology, molecular biology, and hematology disciplines.
Differentiator
Problem solved
Functional benefit
Products and services
- Biochemistry Analyzer
Companies that use CPC Diagnostics
Customer profileSegments2 records
Ideal customer profiles2 records
CPC Diagnostics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
CPC Diagnostics partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights4 records
CPC Diagnostics competitors and assessment
Company assessmentBroad incumbents
- Roche Diagnostics: Global IVD leader with extensive biochemistry, immunoassay, molecular and point-of-care analyzer platforms; competes broadly with CPC Diagnostics across multiple testing modalities in India.
- Mindray: Global medical device and IVD manufacturer with broad chemistry, immunoassay, hematology and POC analyzer lines; a much larger incumbent whose product range overlaps almost entirely with CPC Diagnostics' portfolio.
- Beckman Coulter Diagnostics: Large IVD manufacturer offering AU chemistry, DxI immunoassay and DxH hematology analyzers; its global installed base and reagent pull-through compete with CPC's bundled diagnostic offering.
- Siemens Healthineers: Major diagnostics vendor with Atellica, ADVIA Centaur and Dimension analyzer families spanning chemistry, immunoassay and hematology; competes with CPC Diagnostics across mid- and high-volume lab segments in India.
- Abbott Diagnostics: Global diagnostics major offering chemistry, immunoassay, hematology and POC analyzers (including ARCHITECT and i-STAT lines) that compete with CPC's portfolio across hospital and lab settings.
Direct peers
- Trivitron Healthcare: India-headquartered medical technology company that manufactures and distributes diagnostic instruments and consumables across multiple modalities; competes directly with CPC Diagnostics in the Indian medical lab equipment segment.
- Agappe Diagnostics: Indian IVD company offering biochemistry, hematology, immunoassay and point-of-care analyzers plus reagents; a direct domestic competitor to CPC Diagnostics with overlapping technology categories and Indian lab customer base.
- Transasia Bio-Medicals: India-based manufacturer and supplier of IVD analyzers and reagents across biochemistry, hematology, immunoassay and molecular diagnostics; directly competes with CPC Diagnostics in the Indian clinical lab equipment market with a similarly broad product portfolio.
Emerging players
- Boditech Med (iChroma): South Korean manufacturer of iChroma point-of-care immunoassay analyzers that appear in CPC Diagnostics' product portfolio; a niche emerging player whose technology overlaps directly with CPC's POC segment.
Regional players
- Horiba Medical: Specialist hematology and chemistry analyzer maker competing globally, including in India with its Yumizen and Pentra lines; a regional/adjacent comparable for CPC's hematology and pre-analytical automation offering.
Market position
Strengths5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
CPC Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
CPC Diagnostics leadership team
Management profileNumber of profiles
Profiles2 records
CPC Diagnostics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CPC Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CPC Diagnostics
What does CPC Diagnostics do?
CPC Diagnostics is a dedicated provider of medical laboratory diagnostic equipment to the clinical laboratory industry, supplying analyzers across biochemistry, immunoassay (IFA, CLIA, Trace, Immunoblot), molecular diagnostics, hematology (3-part cell counters and ESR), point-of-care, electrolyte analysis, and pre-analytical automation categories. The company distributes and supports these diagnostic instruments primarily to clinical and medical diagnostic laboratories and to hospitals and clinics in India, offering a multi-modality portfolio under one supplier.
Is CPC Diagnostics a public or private company?
CPC Diagnostics is a private company. It is classified as private equity controlled and is currently operating.
When was CPC Diagnostics founded?
CPC Diagnostics was founded in 1987. It employs 251 to 500 people.
Where is CPC Diagnostics based?
CPC Diagnostics is headquartered in Chennai, India, in the Asia region.
Who are CPC Diagnostics's main competitors?
Broad incumbents on record are Roche Diagnostics, Mindray, Beckman Coulter Diagnostics, Siemens Healthineers and Abbott Diagnostics. Direct peers are Trivitron Healthcare, Agappe Diagnostics and Transasia Bio-Medicals. Boditech Med (iChroma) is listed as an emerging player. Horiba Medical is listed as a regional player.
Does CPC Diagnostics have an API?
No public API is recorded for CPC Diagnostics.